The mRNA expression of IQGAP2 and IQGAP3 was analysed among different cancer stages (I to IV) in lung, breast, stomach, colorectal, prostate, liver and kidney cancer, whereas the expression in brain cancer was compared between the histologic grades (G2 and G3) because of the lack of stage wise data. This evidence concerns the gene IQGAP3 and kidney cancer.